🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could lead to users injecting products of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the platform has taken down problematic material and banned related hashtags and query recommendations. The company said it was committed to keeping the service secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.

Within moments of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Inside these groups, messages show black plastic packages with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly serious medical dangers”.